1.
Chinese Journal of Perinatal Medicine
;
(12): 68-71, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-995066
RESUMEN
Magnesium sulfate has been administered to pregnant women at imminent risk of preterm delivery for fetal neuroprotection, but its adverse effects and target population have not been fully studied. This paper summarizes the current protocols according to the existing guidelines and the latest research progress, including the gestational age at intervention, dose, duration of therapy and the need for re-administration, hoping to provide a reference for the clinical use of magnesium sulfate for fetal neuroprotection in China.